Papyrus Reports Improved TBS Samples As It Targets Commercial Production
PPY: $0.009 +0.00% · MC: $5M
Papyrus Australia says internal testing showed significantly improved performance in a second production-scale board run, with samples now sent to TBS for testing before any move to commercial supply. It also began engaging additional potential customers and says its FY27 priorities include completing TBS acceptance, scaling production and securing funding; shareholders approved all resolutions at the AGM.

Comments